It was reported that CXCL2 could enhance survival of primary chronic lymphocytic leukemia cells in vitro and differential expression of CXCL2 in colon cancer had impact on metastatic disease and survival [28], [29]. The gene discussed is CXCL2; the disease is metastatic neoplasm.